Kozmetik Ürünler ve Kadın Sağlığı

Günümüzde kozmetik ürünler, çok çeşitli etkileri nedeniyle modern toplumun vazgeçilmez bir ürünü olarak karşımıza çıkmaktadır. Genellikle içeriğindeki kimyasal maddelere hiç bakılmadan kullanılan ve hedef kitlesi çoğunlukla kadınlar olan bu ürünler, bilinçsiz kullanıldığında sağlığı olumsuz etkilemektedir. Bu makalede, ilaçlar gibi yasal düzenlemeleri olması gereken kozmetik ürünlerin içeriğindeki bazı kimyasal maddelerin kadın sağlığına etkileri güncel araştırmalarla ele alınmış ve kadınlar başta olmak üzere toplumun kozmetik ürünler konusundaki farkındalığını artırmak amaçlanmıştır.

Cosmetic Products and Womens Health

Due to their various effects, today cosmetic products are indispensable products of modern society. These products which are generally used without considering chemical material in their content and whose target group are generally women influence health negatively when they are used unconsciously. In this paper, the effect of chemical materials in the content of cosmetic products which should be used with legal arrangements on women health was analyzed through recent studies and it was aimed to analyze awareness of society, especially women, about cosmetic products.

PDF

___

1. Demirezer LÖ. Fitokozmesötikler. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2008; 28 (Suppl): S178-S181.
2. Kandi B, Kaya H, Özünal ZG. Kozmetik emilim sistemleri. Türkiye Klinikleri Journal of Cosmetic Dermatology Special Topics. 2012; 5(1): 1-6.
3. Karaduman A. Kozmetikler ve Kadın. Eds.: Akın A. In: Toplumsal cinsiyet, sağlık ve kadın. Ankara: Hacettepe Üniversitesi Yayınları; 2003. p. 175-189.
4. Yazan Y. Kozmetik Bilimi. 2nd edition. Ankara: Nobel Kitabevleri; 2010.
5. Batı U. Reklamcılıkta retorik bir unsur olarak kadın bedeni temsilleri. Kültür ve İletişim. 2010; 13(1):103-133.
6. Papatya N, Karaca Y. Reklamlardaki kadın imgesi: ulusal televizyon reklamlarına ilişkin bir değerlendirme. Süleyman Demirel Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi. 2011; 16(3): 479-500.
7. Gökdemir G, Arı S, Köşlü A. Türk toplumunda deri bakımı ile ilgili bilgi seviyesinin değerlendirilmesi. Türkderm. 2008; 42(2): 60-63.
8. Choi CM, Berson DS. Cosmeceuticals. Seminars in Cutaneous Medicine and Surgery. 2006; 25(3): 163-168.
9. Özer Ö. Bilimden Pratiğe kozmesötikler. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2008; 28 (Suppl): 175-177.
10. Borlu M. Kozmetiklerle oluşan kontakt alerji paternleri. Türkiye Klinikleri Journal of Cosmetic Dermatology Special Topics. 2012; 5(1): 87-93.
11. Millikan LE. Cosmetology, cosmetics, cosmeceuticals: definations and regulations. Clinics Dermatology. 2001;19: 371-374.
12. Çomoğlu T. Kozmetikler. Marmara Pharmaceutical Journal. 2012; 16: 1-8.
13. Brody HJ. Relevance of cosmeceuticals to the dermatologic surgeon. Dermatologic Surgery. 2005; 31: 796-798.
14. Karıncaoğlu Y. Kozmesötikler: mitler ve yanlış bilinenler. Türkiye Klinikleri Journal of Cosmetic Dermatology Special Topics. 2012; 5(1): 94-98.
15. Russ K. Health effects of personal care products. a review of the evidence. Nursing for Womens Health. 2009; 13(5): 392-401.
16. Castanedo-Tardan MP, Zug KA. Patterns of cosmetic allergy. Dermatologic Clinics. 2009; 27(3): 265-280, vi.
17. Scheman A. Adverse reactions to cosmetic ingredients. Dermatologic Clinics. 2000; 18(4): 685-698.
18. Nohynek GJ, Antignac E, Re T, Toutain H. Safety assesment of personal care products/cosmetics and their ingredients. Toxicology and Applied Pharmacology. 2010; 243: 239-259.
19. Kozmetik Yönetmeliği. T.C. Resmi Gazete, 25823, 23 Mayıs 2005.
20. Draelos ZD. Are cosmetics safe? Journal of Cosmetic Dematology. 2012; 11: 249-250.
21. Food and Drug Administration (FDA). 2002. Is it a cosmetic, a drug, or both? (or is it soap?).http://www.fda.gov/cosmetics/guidancecom plianceregulatoryinformation/ucm074201.htm [Acces date: 31.01.2013].
22. Newburger AE. Cosmeceuticals: myths and misconceptions. Clinics in Dermatology. 2009; 27(5): 446-452.
23. Food and Drug Administration (FDA). 2003. Color additives: FDAs regulatory process and historical perspectives. Barrows JN, Lipman AL, Bailey CJ. http://www.fda.gov/ForIndustry/ColorAdditives/Reg ulatoryProcessHistoricalPerspectives/default.htm [Acces date: 31.01.2013].
24. Food and Drug Administration (FDA). 2005. FDA authority over cosmetics. http://www.fda.gov/ Cosmetics/GuidanceComplianceRegulatoryInform ation/ucm074162.htm [Acces date: 31.01.2013].
25. Bakar C, Baba A. Metaller ve insan sağlığı: yirminci yüzyıldan bugüne ve geleceğe miras kalan çevre sağlığı sorunu. I. Tıbbi Jeoloji Çalıştayı, Ürgüp/Nevşehir: 2009. p. 162-185.
26. Durmaz E, Özmert EN. Fitalatlar ve çocuk sağlığı. Çocuk Sağlığı ve Hastalıkları Dergisi. 2010; 53: 305-317.
27. Koniecki D, Wang R, Moody RP, Zhu J. Phtalate in cosmetic and personal care products: concentrations and dermal exposure. Environmental Research. 2011; 111: 329-336.
28. Koo HJ, Lee BM. Estimated exposure to phthalates in cosmetics and risk assessment. Journal of Toxicology and Environmental Health. 2004; 67(23-24): 1901-1914.
29. Pehlivan M, Pehlivan E, Özler MA. İnsan sağlığı üzerine civa ve civa bileşiklerinin etkisi. Çevre Dergisi. 1993; 8: 33-35.
30. Goldman JM, Laws SC, Balchak SK, Cooper RL, Kavlock RJ. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid activity in the female rat. A focus on the EDSTAC recommendations. Critical Reviews in Toxicology. 2000; 30(2): 135-196.
31. Liu T, Wu D. High-performance liquid chromatographic determination of triclosan and triclocarban in cosmetic products. International Journal of Cosmetics Science. 2012; 34: 489-494.
32. Glaser A. The Ubiquitous triclosan. A common antibacterial agent exposed. Pesticides and You Beyond Pesticides/National Coalition Against the Misuse of Pesticides. 2004; 24(3): 12-17.
33. Ballesta Claver J, Valencia MC, Capitán-Vallvey LF. Analysis of parabens in cosmetics by low pressure liquid chromatography with monolithic column and chemiluminescent detection. Talanta. 2009; 79: 499-506.
34. The Campaign for Safe Cosmetics. Parabens. http://safecosmetics.org/article.php?id=291 [Acces date: 10.05.2013].
35. Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MG, Pore GS. Concentration of parabens in human breast tumors. Journal of Applied Toxicology. 2004; 24(1): 5-13.
36. Epstein H. Cosmetics preservation. Clinics in Dermotology. 2006; 24: 551-552.
37. Çetinkaya S. Endokrin bozucular ve ergenlik üzerine etkileri. Dicle Tıp Dergisi. 2009; 36(1): 59-66.
38. European Comission. 2001. Opinion concerning Dialkyl- and Dialkanolamines and their salts in cosmetic products adopted by the SCCNFP during the 17th plenary meeting of 12 June. http://ec.europa.eu/health/scientific_committees/co nsumer_safety/opinions/sccnfp_opinions_97_04/s ccp_out144_en.htm [Acces date: 22.02.2013].
39. Schothorst RC. Somer HHJ. Determination of N- nitrosodiethanolamine in cosmetic products by LC- MS-MS. Analytical and Bioanalytical Chemistry. 2005; 381:681-685.
40. Schlumpf M, Cotton B, Conscience M, Haller V, Steinmann B, Lichtensteiger W. In vitro and in vivo estrogenicity of UV screens. Environmental Health Perspectives. 2001; 109: 239244.
41. Tekbaş ÖF. Kimyasallar ve üreme sağlığı. TSK Koruyucu Hekimlik Bülteni. 2006; 5(1): 50-59.
42. Selevan SG, Rice DC, Hogan KA, Euling SY, Pfahles-Hutchens A, Bethel J. Blood lead concentration and delayed puberty in girls. The New England Journal of Medicine. 2003; 348: 1527-1536.
43. The Campaign for Safe Cosmetics. Hundreds of lipsticks contaminated with lead, reports new FDA study. http://safecosmetics.org/article.php?id=952 [Acces date: 22.02.2013].
44. Food and Drug Administration (FDA). Lipstick and Lead: Questions and Answers. http://www.fda.gov/Cosmetics/ProductandIngredie ntSafety/ProductInformation/ucm137224.htm#exp analyses [Acces date: 22.02.2013].
45. Darbre PD. Enviromental oestrogens, cosmetics and breast cancer. Best Practice & Research Clinical Endocrinology & Metabolism. 2006; 20(1): 121-143.
46. The Campaign for Safe Cosmetics. 1,4 Dioxane. http://safecosmetics.org/article.php?id=288 [Acces date: 10.05.2013].
47. Karadağ ÖK. Solvent nedenli sağlık risklerinin yönetimi. Türk Tabipleri Birliği Mesleki Sağlık ve Güvenlik Dergisi. 2005;21-27.
48. Ünsaldı E, Çiftçi K. Formaldehit, kullanım alanları, risk grubu, zararlı etkileri ve koruyucu önlemler. YYÜ Veteriner Fakültesi Dergisi. 2010;21(7): 71-75.
49. Kireche M, Gimenez-Arnau E, Lepoittevin J-P. Preservatives in cosmetics: reactivity of allergenic formaldehyde-releasers towards amino acids through breakdown products other than formaldehyde. Contact Dermatitis. 2010; 63: 192-202.
50. The Campaign for Safe Cosmetics. Formaldehyde and formaldehyde-releasing preservatives. http://safecosmetics.org/article.php?id=599. [Acces date: 11.05.2013].
51. The Campaign for Safe Cosmetics. Hydroquinone. http://safecosmetics.org/article.php?id=288 [Acces date: 11.05.2013].
52. Löffler H, Freyschmidt-Paul P, Effendy I, Maibach H. Pitfalls of irritant patch testing using different test chamber sizes. American Journal of Contact Dermatitis. 2001; 12(1): 2832.
53. Petrini C, Vecchia P. Statements and definitions of the precautionary principle. IEEE Technology and Society Magazine. Winter 2002/2003; 4-7.